Showing results (1631-1640 of 1,919) with videos related to

Sort By:
Pageof 192
Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences|October 19, 2016
[Diagnosis and treatment of T1a-T1b prostate cancer]Z Liu, C Luo, S Hu, et al.
Nature Communications|August 11, 2019
Myosin IIA and formin dependent mechanosensitivity of filopodia adhesionN O Alieva, A K Efremov, S Hu, et al.
European Journal of Trauma and Emergency Surgery : Official Publication of the European Trauma Society|January 11, 2017
Xuebijing injection treatment inhibits vasopermeability and reduces fluid requirements in a canine burn modelF-B Tang, Y-L Dai, S Hu, et al.
Clinical and Translational Science|April 4, 2017
Influence of OATP1B1 Function on the Disposition of Sorafenib-β-D-GlucuronideS Bins, L van Doorn, M A Phelps, et al.
Expert Opinion on Emerging Drugs|February 24, 2015
Emerging drugs for the treatment of wound healingElizabeth R Zielins, Elizabeth A Brett, Anna Luan, et al.
Science (New York, N.Y.)|April 18, 2015
Skin fibrosis. Identification and isolation of a dermal lineage with intrinsic fibrogenic potentialYuval Rinkevich, Graham G Walmsley, Michael S Hu, et al.
Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|January 16, 2024
[Immunogenicity, safety and immune persistence of the sequential booster with the recombinant protein-based COVID-19 vaccine (CHO cell) in healthy people aged 18-84 years]D Y Yao, Y P Chen, F Ding, et al.
Plastic Surgery International|December 10, 2015
Stem Cell-Based Therapeutics to Improve Wound HealingMichael S Hu, Tripp Leavitt, Samir Malhotra, et al.
Neuroscience|May 20, 2014
Aspirin-triggered Lipoxin A4 attenuates mechanical allodynia in association with inhibiting spinal JAK2/STAT3 signaling in neuropathic pain in ratsZ F Wang, Q Li, S B Liu, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|May 26, 2022
[Real-world study on the efficacy and prognostic predictive biomarker of patients with metastatic non-small cell lung cancer treated with programmed death-1/programmed death ligand 1 inhibitors]W J Zhu, H H Zhu, Y T Liu, et al.
Pageof 192